SERENA

All-in-one platform
same RNA-LNP
at every scale

Accelerate and secure your RNA-LNP development with an intuitive and built to scale instrument. 

 

  • One platform from screening to continuous manufacturing
  • High-quality RNA-LNPs from 250 µL to Liters
  • Identical CQAs at every scale: comparability by design
LNP starter kits

What makes SERENA® unique?

Proof at every scale

RNA-LNPs made with SERENA at 0.25, 0.5, 1 and 60 mL: Z-average 92 to 99 nm, PDI 0.13 to 0.14, encapsulation efficiency 94 to 97 %.
Z-average and PDI sampled over 4 L of continuous production: size stays between 36 and 42 nm (mean 39 nm), PDI between 0.10 and 0.16 (mean 0.13).
RNA-LNP Z-average decreases from 93 nm to 67 nm as injection frequency increases, with PDI between 0.10 and 0.13, at fixed TFR and FRR.

    Every pulse, the same mix, any scale

    In an RNA-LNP, the process is part of the product — any change to the mixing changes your RNA-LNP.
    NanoPulse® mixes in high-frequency pulses, and each pulse mixes the same way at any scales: the RNA-LNP you validate is the one you manufacture.

    Get the NanoPulse® application note

    We’ll email you the PDF. No spam, unsubscribe anytime.

      Interactive 3D view of SERENA®
      Interactive 3D view of SERENA®

      Your path to GMP



      SERENA GMP version

      With you at every step

      Discovery

      Installation

      Long-term support

      SERENA® specifications

      Key specs at a glance.

      SpecificationSERENA® (research use only)
      Volume range250 µL to continuous production
      Large-scale add-on required above 30 mL
      Throughput / TFRUp to 50 L/h, or ~830 mL/min (post-dilution)
      4.5 L/h, or 75 mL/min (pre-dilution)
      FRR range1:1 to 1:10
      Dilution ratio0 to 1:10
      Mixing technologyNanoPulse® active mixing, identical at every scale
      Particle tuning parametersInjection frequency, total flow rate (TFR) and flow rate ratio (FRR), each set independently
      Operating modesSingle run: one batch, from 250 µL
      Sequence: automated series of runs, such as triplicates or parameter screens
      Continuous: uninterrupted, clog-free production (with the large-scale add-on)
      StatusResearch use only (RUO). GMP version available soon

      Ready to discuss your scale-up?

      Talk to one of our formulation experts about taking your RNA-LNP from screening to manufacturing.

      Response within 24 hours. Your data is secure & never shared

        SERENA® resources

        • NanoPulse technology
        • NanoPulse application note

        NanoPulse® technology

        SERENA® is powered by NanoPulse®, our proprietary active-mixing technology. Discover how it keeps mixing conditions identical from µL scale to large-scale manufacturing, and tunes nanoparticle characteristics without changing TFR or FRR.

        Discover NanoPulse

        NanoPulse® application note

        RNA-LNP CQAs across volumes, continuous production, and in vitro and in vivo data.

          Frequently asked questions about SERENA®

          Is SERENA® for research use or for GMP manufacturing?

          SERENA® is currently available for research use only (RUO), built on a GMP-ready design. A GMP version is in development, using the same NanoPulse® mixing mechanism, so a process developed on SERENA® today is designed to transfer to clinical manufacturing without a change of technology.

          What are the minimum and maximum volumes on SERENA®?

          SERENA® covers from 250 µL up to continuous production at 50 L/h of RNA-LNP (post-dilution). Because SERENA® scales by run time rather than by mixer geometry, the mixing conditions stay the same across the whole range.

          What is the difference between SERENA® and TAMARA?

          TAMARA is our microfluidic system for R&D: precise formulation from 200 µL to 30 mL, ideal for screening and preclinical work. SERENA® delivers the same RNA-LNP quality and adds scale-up, from 250 µL to continuous production at 50 L/h (post-dilution), with identical mixing at every scale. Built for teams that need their RNA-LNP to translate to the clinic.

          Can I transfer a formulation developed with another mixing method to SERENA®?

          Yes. Formulations developed by pipette mixing, home-made syringe-pump setups, microfluidics or other methods can be transferred to SERENA®. Because NanoPulse® is a different mixing mechanism, expect a one-time adjustment of injection frequency and flow parameters to match your reference CQAs. Once matched on SERENA®, no further re-optimization is needed as you scale.

          When is SERENA® available?

          SERENA® will be available from Q1 2027.